Skip to main content
OpenTrials

Clinical trial condition

Hemophilia A

Explore clinical trials studying Hemophilia A. Study availability and eligibility vary by location and protocol.

285 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Hemophilia A trial results

Completed

Safety, Efficacy and PK of BIVV001 in Pediatric Patients With Hemophilia A

NCT04759131

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Children's Hospital Los Angeles-Site Number:8400006 Los Angeles, California, United States
  • University of Florida-Site Number:8400009 Gainesville, Florida, United States
  • Children's Healthcare of Atlanta-Site Number:8400019 Atlanta, Georgia, United States
  • Rush University Medical Center-Site Number:8400001 Chicago, Illinois, United States
View all 40 locations
View Trial Details
Completed

Real World Use of Emicizumab in Infants and Children Ages 0-3 Years With Hemophilia A

NCT05248594

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Connecticut Children's Hemophilia Treatment Center - Connecticut Children's Medical Center Hartford, Connecticut, United States
  • Yale Hemophilia Treatment Center New Haven, Connecticut, United States
  • Dartmouth Hitchcock Hemophilia Center - Mary Hitchcock Memorial Hospital Lebanon, New Hampshire, United States
  • Newark Beth Israel Newark, New Jersey, United States
View Trial Details
Completed

Baby Detect : Genomic Newborn Screening

NCT05687474

Conditions
3-Hydroxy 3-Methyl Glutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency, +368 more
Locations
  • CRMN, Hôpital La Citadelle Liège, Wallonia, Belgium
View Trial Details
Completed

A Study of PEGylated Recombinant Factor VIII (BAX855) in Previously Untreated Young Children With Severe Hemophilia A

NCT02615691

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Kaiser Permanente Oakland M.C. Cupertino, California, United States
  • Kaiser Permanente Oakland M.C. Oakland, California, United States
  • Kaiser Permanente Oakland M.C. Roseville, California, United States
View all 91 locations
View Trial Details
Completed

Study to Learn More About the Physical Activity Level of Patients Suffering From Hemophilia A Treated With Damoctocog Alfa Pegol (LIFE ACTIVE Study)

NCT04091386

Conditions
Behavior, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +8 more
Locations
  • Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders Orange, California, United States
  • Tulane University New Orleans, Louisiana, United States
  • Many Locations Multiple Locations, Belgium
  • Many Locations Multiple Locations, Canada
View Trial Details
Completed

Study Evaluating On-Demand Treatment Of Xyntha In Chinese Subjects

NCT00868530

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Pfizer Investigational Site Suzhou, Jiangsu, China
  • Pfizer Investigational Site Heping District, Tianjin Municipality, China
  • Pfizer Investigational Site Hangzhou, Zhejiang, China
  • Pfizer Investigational Site Beijing, China
View Trial Details

Related conditions